Brief: Quantum Genomics granted key European patent for QGC011 combination therapy program

Quantum Genomics SA

02/02/2017 17:08

Feb 2 (Reuters) - Quantum Genomics SA  ALQGC.PA : 
    * Quantum Genomics granted key European patent for QGC011 
combination therapy program 
    * Patent is valid until 2032 and has been filed in 37 member 
states of European Patent Organization 
 
Source text for Eikon:  ID:nACT47280  
Further company coverage:  ALQGC.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))